Marcus Lachlan Hastie

Marcus Lachlan Hastie

UNVERIFIED PROFILE

Are you Marcus Lachlan Hastie?   Register this Author

Register author
Marcus Lachlan Hastie

Marcus Lachlan Hastie

Publications by authors named "Marcus Lachlan Hastie"

Are you Marcus Lachlan Hastie?   Register this Author

4Publications

45Reads

32Profile Views

Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome.

Mol Cell Proteomics 2019 05 31;18(5):818-836. Epub 2019 Jan 31.

From the ‡Queensland University of Technology (QUT), Institute of Health and Biomedical Innovation (IHBI) and School of Biomedical Sciences at the Translational Research Institute, 37 Kent Street, Woolloongabba, Queensland, 4102, Australia;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/mcp.RA118.001304DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495248PMC
May 2019

Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency.

Sci Rep 2017 07 28;7(1):6789. Epub 2017 Jul 28.

Queensland University of Technology (QUT), Institute of Health and Biomedical Innovation (IHBI) and School of Biomedical Sciences at the Translational Research Institute, 37 Kent Street, Woolloongabba, Queensland, 4102, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-017-06680-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533777PMC
July 2017

RELB Alters Proliferation of Human Pluripotent Stem Cells via IMP3- and LIN28-Mediated Modulation of the Expression of IGF2 and Other Cell-Cycle Regulators.

Stem Cells Dev 2015 Aug 5;24(16):1888-900. Epub 2015 May 5.

1 Stem Cell Engineering Group, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland , St. Lucia, QLD, Australia .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/scd.2014.0587DOI Listing
August 2015

Proteomic and other analyses to determine the functional consequences of deregulated kallikrein-related peptidase (KLK) expression in prostate and ovarian cancer.

Proteomics Clin Appl 2014 Jun 11;8(5-6):403-15. Epub 2014 May 11.

Institute of Health and Biomedical Innovation, Translational Research Institute, Queensland University of Technology, Brisbane, Australia; Australian Prostate Cancer Research Centre - Queensland, Translational Research Institute, Queensland University of Technology, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/prca.201300098DOI Listing
June 2014